This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huseby, R. A. Search for Related Content PubMed PubMed Citation Articles by Huseby, R. A.

Demonstration of a Direct Carcinogenic Effect of Estradiol on Leydig Cells of the Mouse¹

Oncology Research Laboratory, Department of Medicine, Henry Ford Hospital Detroit, Michigan 48202

When testes of 1-day-old BALB/c mice were transplanted to the spleen of castrated isologous recipients and a pellet composed of 20% 17ß-estradiol-80% cholesterol was placed next to these explants, typical Leydig cell tumors developed in 14 of 24 grafts that were in close apposition to the estrogen source. No tumors developed in such intrasplenic grafts in eight animals in which the pellet was at a distance from the graft. Also, neither tumors nor areas of Leydig cell hyperplasia developed in the 32 testicular grafts placed in the fourth mammary gland of the same animals.

Grafting of 1-day-old testes to the spleen of castrated untreated males did not result in the development of tumors during a 1-year period of observation, and implantation of a 17ß-estradiol pellet into the spleen of 6-week-old animals resulted in no morphological changes in the Leydig cells unless adhesions between the spleen and the abdominal wall had occurred that resulted in a significant systemic circulation of unmetabolized 17ß-estradiol. A 5-mg 20% 17ß-estradiol pellet implanted in the s.c. tissues was an effective means of producing Leydig cell tumors both in testes in situ and in testes that had been grafted either to the spleen or to the fourth mammary gland.

The results of these experiments indicate that the carcinogenic effect of 17ß-estradiol results from an action of this estrogen directly upon the Leydig cells rather than by either the action of some systemic metabolite or the alteration of the general endocrine status of the animals.

¹ Supported by USPHS Research Grant CA22401 from the National Cancer Institute and the Matilda R. Wilson Fund.

Received 4/10/79. Accepted 12/27/79.

This article has been cited by other articles:

				M. H. Tong, L. K. Christenson, and W.-C. Song Aberrant Cholesterol Transport and Impaired Steroidogenesis in Leydig Cells Lacking Estrogen Sulfotransferase Endocrinology, May 1, 2004; 145(5): 2487 - 2497. [Abstract] [Full Text] [PDF]

				X. Li, L. Strauss, S. Makela, T. Streng, I. Huhtaniemi, R. Santti, and M. Poutanen Multiple Structural and Functional Abnormalities in the P450 Aromatase Expressing Transgenic Male Mice Are Ameliorated by a P450 Aromatase Inhibitor Am. J. Pathol., March 1, 2004; 164(3): 1039 - 1048. [Abstract] [Full Text] [PDF]

				Y. M. Qian, X. J. Sun, M. H. Tong, X. P. Li, J. Richa, and W.-C. Song Targeted Disruption of the Mouse Estrogen Sulfotransferase Gene Reveals a Role of Estrogen Metabolism in Intracrine and Paracrine Estrogen Regulation Endocrinology, December 1, 2001; 142(12): 5342 - 5350. [Abstract] [Full Text] [PDF]

				R. R. Newbold, R. B. Hanson, W. N. Jefferson, B. C. Bullock, J. Haseman, and J. A. McLachlan Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol Carcinogenesis, July 1, 2000; 21(7): 1355 - 1363. [Abstract] [Full Text] [PDF]

				J. G. Liehr Is Estradiol a Genotoxic Mutagenic Carcinogen? Endocr. Rev., February 1, 2000; 21(1): 40 - 54. [Abstract] [Full Text]

				T. Klonisch, R. Ivell, M. Balvers, S. Kliesch, B. Fischer, M. Bergmann, and K. Steger Expression of relaxin-like factor is down-regulated in human testicular Leydig cell neoplasia Mol. Hum. Reprod., February 1, 1999; 5(2): 104 - 108. [Abstract] [Full Text] [PDF]